APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Drug Target Discovery Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AI Drug Target Discovery Service Market Outlook and Growth Opportunities 2026

3 July 2026213 pages

Choose your research edition.

Industry ResearchAI Drug Target Discovery Service Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Drug Target Discovery Service Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal AI Drug Target Discovery Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Drug Target Discovery Service Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Drug Target Discovery Service Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global AI Drug Target Discovery Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI Drug Target Discovery Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Drug Target Discovery Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Drug Target Discovery Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI Drug Target Discovery Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI Drug Target Discovery Service market include Exscientia, Atomwise, Benevolent AI, Insitro, Xaira Therapeutics, Tempus AI, AbCellera, Recursion and Iktos, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI Drug Target Discovery Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Drug Target Discovery Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Drug Target Discovery Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI Drug Target Discovery Service market.

AI Drug Target Discovery Service Segment by Company

Exscientia

Atomwise

Benevolent AI

Insitro

Xaira Therapeutics

Tempus AI

AbCellera

Recursion

Iktos

Genialis

Anima Biotech

BPGbio

Cradle

Isomorphic Labs

Generate Biomedicines

Latent Labs

Relay Therapeutics

Model Medicines

Nimbus Therapeutics

Schrödinger

XtalPi

Insilico Medicine

Drug Farm

BioMap

AI Drug Target Discovery Service Segment by Type

Target Identification Based on Omics Data and Biological Networks

Target Mining Based on Literature and Knowledge Graphs

Target Prediction Based on Structural Bioinformatics

Target Discovery Based on Phenotypic Screening and Virtual Patients

AI Drug Target Discovery Service Segment by Application

Pharmaceutical Company

CRO and Universities

Others

AI Drug Target Discovery Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI Drug Target Discovery Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI Drug Target Discovery Service key companies, revenue, market share, and recent developments.

3. To split the AI Drug Target Discovery Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI Drug Target Discovery Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI Drug Target Discovery Service significant trends, drivers, influence factors in global and regions.

6. To analyze AI Drug Target Discovery Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Drug Target Discovery Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Drug Target Discovery Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Drug Target Discovery Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Drug Target Discovery Service industry.

Chapter 3: Detailed analysis of AI Drug Target Discovery Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI Drug Target Discovery Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI Drug Target Discovery Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI Drug Target Discovery Service Industry Trends Table 2. AI Drug Target Discovery Service Industry Drivers Table 3. AI Drug Target Discovery Service Industry Opportunities and Challenges Table 4. AI Drug Target Discovery Service Industry Restraints Table 5. Global AI Drug Target Discovery Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI Drug Target Discovery Service Revenue Share by Company (2021-2026) Table 7. Global AI Drug Target Discovery Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI Drug Target Discovery Service Key Company Manufacturing Base & Headquarters Table 9. Global AI Drug Target Discovery Service Company, Product Type & Application Table 10. Global AI Drug Target Discovery Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI Drug Target Discovery Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Target Identification Based on Omics Data and Biological Networks Table 15. Significant Companies of Target Mining Based on Literature and Knowledge Graphs Table 16. Significant Companies of Target Prediction Based on Structural Bioinformatics Table 17. Significant Companies of Target Discovery Based on Phenotypic Screening and Virtual Patients Table 18. Global AI Drug Target Discovery Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global AI Drug Target Discovery Service Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global AI Drug Target Discovery Service Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global AI Drug Target Discovery Service Sales Value Share by Type (2021-2026) Table 22. Global AI Drug Target Discovery Service Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Pharmaceutical Company Table 24. Significant Companies of CRO and Universities Table 25. Significant Companies of Others Table 26. Global AI Drug Target Discovery Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global AI Drug Target Discovery Service Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global AI Drug Target Discovery Service Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global AI Drug Target Discovery Service Sales Value Share by Application (2021-2026) Table 30. Global AI Drug Target Discovery Service Sales Value Share by Application (2027-2032) Table 31. Global AI Drug Target Discovery Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global AI Drug Target Discovery Service Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global AI Drug Target Discovery Service Sales Value Share by Region (2021-2026) Table 34. Global AI Drug Target Discovery Service Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global AI Drug Target Discovery Service Sales Value Share by Region (2027-2032) Table 36. Global AI Drug Target Discovery Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global AI Drug Target Discovery Service Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global AI Drug Target Discovery Service Sales Value Market Share by Country (2021-2026) Table 39. Global AI Drug Target Discovery Service Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global AI Drug Target Discovery Service Sales Value Market Share by Country (2027-2032) Table 41. Exscientia Company Information Table 42. Exscientia Business Overview Table 43. Exscientia AI Drug Target Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Exscientia AI Drug Target Discovery Service Product Portfolio Table 45. Exscientia Recent Development Table 46. Atomwise Company Information Table 47. Atomwise Business Overview Table 48. Atomwise AI Drug Target Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Atomwise AI Drug Target Discovery Service Product Portfolio Table 50. Atomwise Recent Development Table 51. Benevolent AI Company Information Table 52. Benevolent AI Business Overview Table 53. Benevolent AI AI Drug Target Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Benevolent AI AI Drug Target Discovery Service Product Portfolio Table 55. Benevolent AI Recent Development Table 56. Insitro Company Information Table 57. Insitro Business Overview Table 58. Insitro AI Drug Target Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Insitro AI Drug Target Discovery Service Product Portfolio Table 60. Insitro Recent Development Table 61. Xaira Therapeutics Company Information Table 62. Xaira Therapeutics Business Overview Table 63. Xaira Therapeutics AI Drug Target Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Xaira Therapeutics AI Drug Target Discovery Service Product Portfolio Table 65. Xaira Therapeutics Recent Development Table 66. Tempus AI Company Information Table 67. Tempus AI Business Overview Table 68. Tempus AI AI Drug Target Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Tempus AI AI Drug Target Discovery Service Product Portfolio Table 70. Tempus AI Recent Development Table 71. AbCellera Company Information Table 72. AbCellera Business Overview Table 73. AbCellera AI Drug Target Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. AbCellera AI Drug Target Discovery Service Product Portfolio Table 75. AbCellera Recent Development Table 76. Recursion Company Information Table 77. Recursion Business Overview Table 78. Recursion AI Drug Target Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Recursion AI Drug Target Discovery Service Product Portfolio Table 80. Recursion Recent Development Table 81. Iktos Company Information Table 82. Iktos Business Overview Table 83. Iktos AI Drug Target Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Iktos AI Drug Target Discovery Service Product Portfolio Table 85. Iktos Recent Development Table 86. Genialis Company Information Table 87. Genialis Business Overview Table 88. Genialis AI Drug Target Discovery Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Genialis AI Drug Target Discovery Service Product Portfolio Table 90. Genialis Recent Development Table 91. Anima Biotech Company Information Table 92. Anima Biotech Business Overview Table 93. Anima Biotech AI Drug Target Discovery Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Anima Biotech AI Drug Target Discovery Service Product Portfolio Table 95. Anima Biotech Recent Development Table 96. BPGbio Company Information Table 97. BPGbio Business Overview Table 98. BPGbio AI Drug Target Discovery Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. BPGbio AI Drug Target Discovery Service Product Portfolio Table 100. BPGbio Recent Development Table 101. Cradle Company Information Table 102. Cradle Business Overview Table 103. Cradle AI Drug Target Discovery Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Cradle AI Drug Target Discovery Service Product Portfolio Table 105. Cradle Recent Development Table 106. Isomorphic Labs Company Information Table 107. Isomorphic Labs Business Overview Table 108. Isomorphic Labs AI Drug Target Discovery Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Isomorphic Labs AI Drug Target Discovery Service Product Portfolio Table 110. Isomorphic Labs Recent Development Table 111. Generate Biomedicines Company Information Table 112. Generate Biomedicines Business Overview Table 113. Generate Biomedicines AI Drug Target Discovery Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Generate Biomedicines AI Drug Target Discovery Service Product Portfolio Table 115. Generate Biomedicines Recent Development Table 116. Latent Labs Company Information Table 117. Latent Labs Business Overview Table 118. Latent Labs AI Drug Target Discovery Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Latent Labs AI Drug Target Discovery Service Product Portfolio Table 120. Latent Labs Recent Development Table 121. Relay Therapeutics Company Information Table 122. Relay Therapeutics Business Overview Table 123. Relay Therapeutics AI Drug Target Discovery Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Relay Therapeutics AI Drug Target Discovery Service Product Portfolio Table 125. Relay Therapeutics Recent Development Table 126. Model Medicines Company Information Table 127. Model Medicines Business Overview Table 128. Model Medicines AI Drug Target Discovery Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Model Medicines AI Drug Target Discovery Service Product Portfolio Table 130. Model Medicines Recent Development Table 131. Nimbus Therapeutics Company Information Table 132. Nimbus Therapeutics Business Overview Table 133. Nimbus Therapeutics AI Drug Target Discovery Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Nimbus Therapeutics AI Drug Target Discovery Service Product Portfolio Table 135. Nimbus Therapeutics Recent Development Table 136. Schrödinger Company Information Table 137. Schrödinger Business Overview Table 138. Schrödinger AI Drug Target Discovery Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Schrödinger AI Drug Target Discovery Service Product Portfolio Table 140. Schrödinger Recent Development Table 141. XtalPi Company Information Table 142. XtalPi Business Overview Table 143. XtalPi AI Drug Target Discovery Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. XtalPi AI Drug Target Discovery Service Product Portfolio Table 145. XtalPi Recent Development Table 146. Insilico Medicine Company Information Table 147. Insilico Medicine Business Overview Table 148. Insilico Medicine AI Drug Target Discovery Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Insilico Medicine AI Drug Target Discovery Service Product Portfolio Table 150. Insilico Medicine Recent Development Table 151. Drug Farm Company Information Table 152. Drug Farm Business Overview Table 153. Drug Farm AI Drug Target Discovery Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. Drug Farm AI Drug Target Discovery Service Product Portfolio Table 155. Drug Farm Recent Development Table 156. BioMap Company Information Table 157. BioMap Business Overview Table 158. BioMap AI Drug Target Discovery Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 159. BioMap AI Drug Target Discovery Service Product Portfolio Table 160. BioMap Recent Development Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. AI Drug Target Discovery Service Product Image Figure 2. Global AI Drug Target Discovery Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Drug Target Discovery Service Market Size (2021-2032) & (US$ Million) Figure 4. Global AI Drug Target Discovery Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Target Identification Based on Omics Data and Biological Networks Image Figure 8. Target Mining Based on Literature and Knowledge Graphs Image Figure 9. Target Prediction Based on Structural Bioinformatics Image Figure 10. Target Discovery Based on Phenotypic Screening and Virtual Patients Image Figure 11. Global AI Drug Target Discovery Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global AI Drug Target Discovery Service Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global AI Drug Target Discovery Service Sales Value Share by Type (2021-2032) Figure 14. Pharmaceutical Company Image Figure 15. CRO and Universities Image Figure 16. Others Image Figure 17. Global AI Drug Target Discovery Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global AI Drug Target Discovery Service Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global AI Drug Target Discovery Service Sales Value Share by Application (2021-2032) Figure 20. Global AI Drug Target Discovery Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global AI Drug Target Discovery Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America AI Drug Target Discovery Service Sales Value (2021-2032) & (US$ Million) Figure 23. North America AI Drug Target Discovery Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe AI Drug Target Discovery Service Sales Value (2021-2032) & (US$ Million) Figure 25. Europe AI Drug Target Discovery Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific AI Drug Target Discovery Service Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific AI Drug Target Discovery Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America AI Drug Target Discovery Service Sales Value (2021-2032) & (US$ Million) Figure 29. South America AI Drug Target Discovery Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa AI Drug Target Discovery Service Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa AI Drug Target Discovery Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Target Identification Based on Omics Data and Biological Networks
  • Target Mining Based on Literature and Knowledge Graphs
  • Target Prediction Based on Structural Bioinformatics
  • Target Discovery Based on Phenotypic Screening and Virtual Patients
Applications
  • Pharmaceutical Company
  • CRO and Universities
  • Others
Companies covered
  • Exscientia
  • Atomwise
  • Benevolent AI
  • Insitro
  • Xaira Therapeutics
  • Tempus AI
  • AbCellera
  • Recursion
  • Iktos
  • Genialis
  • Anima Biotech
  • BPGbio
  • Cradle
  • Isomorphic Labs
  • Generate Biomedicines
  • Latent Labs
  • Relay Therapeutics
  • Model Medicines
  • Nimbus Therapeutics
  • Schrödinger
  • XtalPi
  • Insilico Medicine
  • Drug Farm
  • BioMap

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI Drug Target Discovery Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI Drug Target Discovery Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI Drug Target Discovery Service Market Dynamics
  1. 2.1 AI Drug Target Discovery Service Industry Trends
  2. 2.2 AI Drug Target Discovery Service Industry Drivers
  3. 2.3 AI Drug Target Discovery Service Industry Opportunities and Challenges
  4. 2.4 AI Drug Target Discovery Service Industry Restraints
3 AI Drug Target Discovery Service Market by Company
  1. 3.1 Global AI Drug Target Discovery Service Company Revenue Ranking in 2025
  2. 3.2 Global AI Drug Target Discovery Service Revenue by Company (2021-2026)
  3. 3.3 Global AI Drug Target Discovery Service Company Ranking (2024-2026)
  4. 3.4 Global AI Drug Target Discovery Service Company Manufacturing Base and Headquarters
  5. 3.5 Global AI Drug Target Discovery Service Company Product Type and Application
  6. 3.6 Global AI Drug Target Discovery Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI Drug Target Discovery Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI Drug Target Discovery Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI Drug Target Discovery Service Market by Type
  1. 4.1 AI Drug Target Discovery Service Type Introduction
  2. 4.1.1 Target Identification Based on Omics Data and Biological Networks
  3. 4.1.2 Target Mining Based on Literature and Knowledge Graphs
  4. 4.1.3 Target Prediction Based on Structural Bioinformatics
  5. 4.1.4 Target Discovery Based on Phenotypic Screening and Virtual Patients
  6. 4.2 Global AI Drug Target Discovery Service Sales Value by Type
  7. 4.2.1 Global AI Drug Target Discovery Service Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global AI Drug Target Discovery Service Sales Value by Type (2021-2032)
  9. 4.2.3 Global AI Drug Target Discovery Service Sales Value Share by Type (2021-2032)
5 AI Drug Target Discovery Service Market by Application
  1. 5.1 AI Drug Target Discovery Service Application Introduction
  2. 5.1.1 Pharmaceutical Company
  3. 5.1.2 CRO and Universities
  4. 5.1.3 Others
  5. 5.2 Global AI Drug Target Discovery Service Sales Value by Application
  6. 5.2.1 Global AI Drug Target Discovery Service Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global AI Drug Target Discovery Service Sales Value by Application (2021-2032)
  8. 5.2.3 Global AI Drug Target Discovery Service Sales Value Share by Application (2021-2032)
6 AI Drug Target Discovery Service Regional Value Analysis
  1. 6.1 Global AI Drug Target Discovery Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI Drug Target Discovery Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI Drug Target Discovery Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI Drug Target Discovery Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI Drug Target Discovery Service Sales Value (2021-2032)
  7. 6.3.2 North America AI Drug Target Discovery Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI Drug Target Discovery Service Sales Value (2021-2032)
  10. 6.4.2 Europe AI Drug Target Discovery Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI Drug Target Discovery Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI Drug Target Discovery Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI Drug Target Discovery Service Sales Value (2021-2032)
  16. 6.6.2 South America AI Drug Target Discovery Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI Drug Target Discovery Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI Drug Target Discovery Service Sales Value Share by Country, 2025 VS 2032
7 AI Drug Target Discovery Service Country-level Value Analysis
  1. 7.1 Global AI Drug Target Discovery Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI Drug Target Discovery Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI Drug Target Discovery Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI Drug Target Discovery Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI Drug Target Discovery Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI Drug Target Discovery Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI Drug Target Discovery Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Exscientia
  2. 8.1.1 Exscientia Company Information
  3. 8.1.2 Exscientia Business Overview
  4. 8.1.3 Exscientia AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Exscientia AI Drug Target Discovery Service Product Portfolio
  6. 8.1.5 Exscientia Recent Developments
  7. 8.2 Atomwise
  8. 8.2.1 Atomwise Company Information
  9. 8.2.2 Atomwise Business Overview
  10. 8.2.3 Atomwise AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Atomwise AI Drug Target Discovery Service Product Portfolio
  12. 8.2.5 Atomwise Recent Developments
  13. 8.3 Benevolent AI
  14. 8.3.1 Benevolent AI Company Information
  15. 8.3.2 Benevolent AI Business Overview
  16. 8.3.3 Benevolent AI AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Benevolent AI AI Drug Target Discovery Service Product Portfolio
  18. 8.3.5 Benevolent AI Recent Developments
  19. 8.4 Insitro
  20. 8.4.1 Insitro Company Information
  21. 8.4.2 Insitro Business Overview
  22. 8.4.3 Insitro AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Insitro AI Drug Target Discovery Service Product Portfolio
  24. 8.4.5 Insitro Recent Developments
  25. 8.5 Xaira Therapeutics
  26. 8.5.1 Xaira Therapeutics Company Information
  27. 8.5.2 Xaira Therapeutics Business Overview
  28. 8.5.3 Xaira Therapeutics AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Xaira Therapeutics AI Drug Target Discovery Service Product Portfolio
  30. 8.5.5 Xaira Therapeutics Recent Developments
  31. 8.6 Tempus AI
  32. 8.6.1 Tempus AI Company Information
  33. 8.6.2 Tempus AI Business Overview
  34. 8.6.3 Tempus AI AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Tempus AI AI Drug Target Discovery Service Product Portfolio
  36. 8.6.5 Tempus AI Recent Developments
  37. 8.7 AbCellera
  38. 8.7.1 AbCellera Company Information
  39. 8.7.2 AbCellera Business Overview
  40. 8.7.3 AbCellera AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 AbCellera AI Drug Target Discovery Service Product Portfolio
  42. 8.7.5 AbCellera Recent Developments
  43. 8.8 Recursion
  44. 8.8.1 Recursion Company Information
  45. 8.8.2 Recursion Business Overview
  46. 8.8.3 Recursion AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Recursion AI Drug Target Discovery Service Product Portfolio
  48. 8.8.5 Recursion Recent Developments
  49. 8.9 Iktos
  50. 8.9.1 Iktos Company Information
  51. 8.9.2 Iktos Business Overview
  52. 8.9.3 Iktos AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Iktos AI Drug Target Discovery Service Product Portfolio
  54. 8.9.5 Iktos Recent Developments
  55. 8.10 Genialis
  56. 8.10.1 Genialis Company Information
  57. 8.10.2 Genialis Business Overview
  58. 8.10.3 Genialis AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Genialis AI Drug Target Discovery Service Product Portfolio
  60. 8.10.5 Genialis Recent Developments
  61. 8.11 Anima Biotech
  62. 8.11.1 Anima Biotech Company Information
  63. 8.11.2 Anima Biotech Business Overview
  64. 8.11.3 Anima Biotech AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Anima Biotech AI Drug Target Discovery Service Product Portfolio
  66. 8.11.5 Anima Biotech Recent Developments
  67. 8.12 BPGbio
  68. 8.12.1 BPGbio Company Information
  69. 8.12.2 BPGbio Business Overview
  70. 8.12.3 BPGbio AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 BPGbio AI Drug Target Discovery Service Product Portfolio
  72. 8.12.5 BPGbio Recent Developments
  73. 8.13 Cradle
  74. 8.13.1 Cradle Company Information
  75. 8.13.2 Cradle Business Overview
  76. 8.13.3 Cradle AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cradle AI Drug Target Discovery Service Product Portfolio
  78. 8.13.5 Cradle Recent Developments
  79. 8.14 Isomorphic Labs
  80. 8.14.1 Isomorphic Labs Company Information
  81. 8.14.2 Isomorphic Labs Business Overview
  82. 8.14.3 Isomorphic Labs AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Isomorphic Labs AI Drug Target Discovery Service Product Portfolio
  84. 8.14.5 Isomorphic Labs Recent Developments
  85. 8.15 Generate Biomedicines
  86. 8.15.1 Generate Biomedicines Company Information
  87. 8.15.2 Generate Biomedicines Business Overview
  88. 8.15.3 Generate Biomedicines AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Generate Biomedicines AI Drug Target Discovery Service Product Portfolio
  90. 8.15.5 Generate Biomedicines Recent Developments
  91. 8.16 Latent Labs
  92. 8.16.1 Latent Labs Company Information
  93. 8.16.2 Latent Labs Business Overview
  94. 8.16.3 Latent Labs AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Latent Labs AI Drug Target Discovery Service Product Portfolio
  96. 8.16.5 Latent Labs Recent Developments
  97. 8.17 Relay Therapeutics
  98. 8.17.1 Relay Therapeutics Company Information
  99. 8.17.2 Relay Therapeutics Business Overview
  100. 8.17.3 Relay Therapeutics AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Relay Therapeutics AI Drug Target Discovery Service Product Portfolio
  102. 8.17.5 Relay Therapeutics Recent Developments
  103. 8.18 Model Medicines
  104. 8.18.1 Model Medicines Company Information
  105. 8.18.2 Model Medicines Business Overview
  106. 8.18.3 Model Medicines AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Model Medicines AI Drug Target Discovery Service Product Portfolio
  108. 8.18.5 Model Medicines Recent Developments
  109. 8.19 Nimbus Therapeutics
  110. 8.19.1 Nimbus Therapeutics Company Information
  111. 8.19.2 Nimbus Therapeutics Business Overview
  112. 8.19.3 Nimbus Therapeutics AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Nimbus Therapeutics AI Drug Target Discovery Service Product Portfolio
  114. 8.19.5 Nimbus Therapeutics Recent Developments
  115. 8.20 Schrödinger
  116. 8.20.1 Schrödinger Company Information
  117. 8.20.2 Schrödinger Business Overview
  118. 8.20.3 Schrödinger AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Schrödinger AI Drug Target Discovery Service Product Portfolio
  120. 8.20.5 Schrödinger Recent Developments
  121. 8.21 XtalPi
  122. 8.21.1 XtalPi Company Information
  123. 8.21.2 XtalPi Business Overview
  124. 8.21.3 XtalPi AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  125. 8.21.4 XtalPi AI Drug Target Discovery Service Product Portfolio
  126. 8.21.5 XtalPi Recent Developments
  127. 8.22 Insilico Medicine
  128. 8.22.1 Insilico Medicine Company Information
  129. 8.22.2 Insilico Medicine Business Overview
  130. 8.22.3 Insilico Medicine AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Insilico Medicine AI Drug Target Discovery Service Product Portfolio
  132. 8.22.5 Insilico Medicine Recent Developments
  133. 8.23 Drug Farm
  134. 8.23.1 Drug Farm Company Information
  135. 8.23.2 Drug Farm Business Overview
  136. 8.23.3 Drug Farm AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Drug Farm AI Drug Target Discovery Service Product Portfolio
  138. 8.23.5 Drug Farm Recent Developments
  139. 8.24 BioMap
  140. 8.24.1 BioMap Company Information
  141. 8.24.2 BioMap Business Overview
  142. 8.24.3 BioMap AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  143. 8.24.4 BioMap AI Drug Target Discovery Service Product Portfolio
  144. 8.24.5 BioMap Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst